Stock comparison
BECTON DICKINSON & CO is 22.0x more valuable than Pulse Biosciences, Inc. by market capitalization ($41.57 B vs $1.89 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BDX is larger
BECTON DICKINSON & CO is 22.0x more valuable than Pulse Biosciences, Inc. by market capitalization ($41.57 B vs $1.89 B).
Market value leader
BDX
BECTON DICKINSON & CO is 22.0x more valuable than Pulse Biosciences, Inc. by market capitalization ($41.57 B vs $1.89 B).
Revenue leader
BDX
PLSE: $350.00K vs BDX: $21.84B.
Profit leader
BDX
PLSE: -$72.78M vs BDX: $1.68B.
Margin leader
BDX
PLSE: -20794.6% vs BDX: 7.7% net margin.
| Metric | PLSE | BDX |
|---|---|---|
| Market cap | $1.89 B | $41.57 B |
| US-listed rank | #2196 | #373 |
| Revenue (latest FY) | $350.00K | $21.84B |
| Net income (latest FY) | -$72.78M | $1.68B |
| Net margin | -20794.6% | 7.7% |
| P/E (trailing FY) | - | 24.8x |
| SEC filings | 616 | 3,027 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BECTON DICKINSON & CO is 22.0x more valuable than Pulse Biosciences, Inc. by market capitalization ($41.57 B vs $1.89 B).
In their latest fiscal years, Pulse Biosciences, Inc. reported $350.00K in revenue while BECTON DICKINSON & CO reported $21.84B.
Full pages: Pulse Biosciences, Inc. and BECTON DICKINSON & CO, or browse the full rankings.